echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Deciphering the detailed structure of the disease-causing protein of Parkinson's disease. Researchers open up a new way for the development of new drugs...

    Deciphering the detailed structure of the disease-causing protein of Parkinson's disease. Researchers open up a new way for the development of new drugs...

    • Last Update: 2021-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Parkinson's disease (PD) is a common neurodegenerative disease that affects at least one in every 100 people over the age of 60


    Scientists studying the pathogenesis of Parkinson's disease have discovered that mutations in a protease called LRRK2 are one of the key causes of familial and occasional Parkinson's disease


    A few days ago, the top academic journal "Cell" published a research paper online.


    Protease LRRK2 participates in a variety of cellular physiological processes.


    In view of the importance of LRRK2, some previous studies have already understood part of the domain of LRRK2 protein


    "There are about 600 kinases in the human body, and all kinases look very similar.


    The high-resolution structure of full-length LRRK2 allows researchers to identify some "disease hotspots" in the molecule, where multiple mutations known to cause disease occur


    One of the most common mutant forms of LRRK2 is called G2019S, which is known to cause Parkinson's disease


    ▲Full-length LRRK2 structure in inactivated state (picture source: reference [1])

    ▲Full-length LRRK2 structure in inactivated state (picture source: reference [1])

    More importantly, the researchers not only determined the structure of a single LRRK2 molecule (ie "monomer"), but also determined the structure of two connected LRRK2 molecules (ie, "dimers"), which provides for further study of the functions of LRRK2


    "Under real physiological conditions, LRRK2 is only active in its dimer form," Dr.


    Using this structure, the researchers also proposed a new treatment for Parkinson's disease


    Note: The original text has been deleted

    Reference

    Reference

    [1] Alexander Myasnikov et al.


    [1] Alexander Myasnikov et al.


    [2] Structure of enzyme that causes Parkinson's promises pathways to new drugs.
    Retrieved June 9, 2021 from https:// -enzyme-that-causes-parkinsons-promises-pathways-to-new-drugs.
    html
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.